Norges Bank’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-199,780
| Closed | -$5.51M | – | 1897 |
|
|
2023
Q4 | $5.51M | Buy |
199,780
+197,910
| +10,583% | +$12.1M | ﹤0.01% | 1652 |
|
|
2023
Q3 | $114K | Hold |
1,870
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q2 | $123K | Hold |
1,870
| – | – | ﹤0.01% | 2001 |
|
|
2023
Q1 | $119K | Hold |
1,870
| – | – | ﹤0.01% | 2082 |
|
|
2022
Q4 | $259K | Hold |
1,870
| – | – | ﹤0.01% | 2111 |
|
|
2022
Q3 | $237K | Hold |
1,870
| – | – | ﹤0.01% | 2073 |
|
|
2022
Q2 | $155K | Hold |
1,870
| – | – | ﹤0.01% | 2042 |
|
|
2022
Q1 | $181K | Sell |
1,870
-18,792
| -91% | -$2.48M | ﹤0.01% | 2143 |
|
|
2021
Q4 | $4.13M | Sell |
20,662
-19,988
| -49% | -$4.72M | ﹤0.01% | 1934 |
|
|
2021
Q3 | $10.1M | Buy |
40,650
+2,019
| +5% | +$577K | ﹤0.01% | 1762 |
|
|
2021
Q2 | $16M | Buy |
38,631
+7,318
| +23% | +$2.9M | ﹤0.01% | 1633 |
|
|
2021
Q1 | $12.2M | Sell |
31,313
-25,828
| -45% | -$12.7M | ﹤0.01% | 1731 |
|
|
2020
Q4 | $32M | Buy |
57,141
+2,743
| +5% | +$1.74M | 0.01% | 1274 |
|
|
2020
Q3 | $38M | Buy |
54,398
+8,590
| +19% | +$6.7M | 0.01% | 998 |
|
|
2020
Q2 | $36.2M | Buy |
45,808
+8,329
| +22% | +$6.28M | 0.01% | 1061 |
|
|
2020
Q1 | $22.3M | Buy |
37,479
+849
| +2% | +$827K | 0.01% | 1179 |
|
|
2019
Q4 | $41.6M | Hold |
36,630
| – | – | 0.01% | 1039 |
|
|
2019
Q3 | $43.6M | Hold |
36,630
| – | – | 0.01% | 949 |
|
|
2019
Q2 | $60.4M | Buy |
36,630
+1,402
| +4% | +$2.43M | 0.02% | 765 |
|
|
2019
Q1 | $71.8M | Buy |
35,228
+1,130
| +3% | +$1.99M | 0.02% | 637 |
|
|
2018
Q4 | $43.8M | Buy |
34,098
+1,769
| +5% | +$2.71M | 0.02% | 837 |
|
|
2018
Q3 | $61.1M | Buy |
32,329
+386
| +1% | +$797K | 0.02% | 722 |
|
|
2018
Q2 | $64.9M | Sell |
31,943
-2,886
| -8% | -$6.58M | 0.02% | 668 |
|
|
2018
Q1 | $77M | Buy |
34,829
+4,084
| +13% | +$10.4M | 0.03% | 581 |
|
|
2017
Q4 | $70.9M | Buy |
30,745
+1,158
| +4% | +$2.35M | 0.03% | 613 |
|
|
2017
Q3 | $52.6M | Hold |
29,587
| – | – | 0.02% | 746 |
|
|
2017
Q2 | $40.3M | Buy |
29,587
+885
| +3% | +$1.07M | 0.02% | 897 |
|
|
2017
Q1 | $33.8M | Hold |
28,702
| – | – | 0.01% | 991 |
|
|
2016
Q4 | $22.9M | Sell |
28,702
-3,924
| -12% | -$3.12M | 0.01% | 1222 |
|
|
2016
Q3 | $27.4M | Buy |
32,626
+14,051
| +76% | +$10.2M | 0.01% | 1002 |
|
|
2016
Q2 | $10.4M | Sell |
18,575
-48
| -0.3% | -$27.2K | ﹤0.01% | 1591 |
|
|
2016
Q1 | $10.3M | Hold |
18,623
| – | – | 0.01% | 1551 |
|
|
2015
Q4 | $15.5M | Buy |
18,623
+952
| +5% | +$951K | 0.01% | 1317 |
|
|
2015
Q3 | $19.6M | Sell |
17,671
-862
| -5% | -$1.57M | 0.01% | 1142 |
|
|
2015
Q2 | $40.4M | Buy |
18,533
+7,792
| +73% | +$15.9M | 0.02% | 761 |
|
|
2015
Q1 | $16.8M | Buy |
+10,741
| New | +$14.2M | 0.01% | 1304 |
|
Other funds holding BLUE
GIM
PAI
TCM
Norges Bank's BLUE Position: Q1 2024 in Review
Norges Bank sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 199,780 shares — an estimated $5.51M sold.
Norges Bank first reported a position in BLUE in Q1 2015 and held it in 36 quarters. The position peaked at $77M in Q1 2018. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Norges Bank reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Norges Bank sold 199,780 bluebird bio shares in Q1 2024, an estimated $5.51M.
- Norges Bank first reported a position in bluebird bio in Q1 2015 and held it in 36 quarters.
- Norges Bank's bluebird bio position peaked at $77M in Q1 2018.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.